Federal agencies must stop disbursing financial assistance starting at 5 p.m. today under a new budget directive, threatening funding for providers and creating significant uncertainty for Medicaid payments to states.
Trump freezes federal grants with big potential impact on providers, Medicaid Read More »
The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for treatment-resistant depression, could serve to further bolster a space hit hard by the rejection of Lykos’ MDMA-based PTSD therapy in August 2024.
Atai Touts Positive Data for Psychedelic Therapy in Alcohol Use Disorder Read More »
The company uses various medical devices to noninvasively check moles, the heart and more.
Neko Health raises $260M to expand body scan service, fund R&D Read More »
Atara Biotherapeutics’ layoffs could leave the biotech with around 80 employees. The cuts follow news that the FDA rejected Ebvallo, a T cell therapy approved in Europe for a transplant-related blood cancer, and placed a clinical hold on the company’s active drug applications.
Atara to Cut Half Its Workforce Following FDA-Related Setbacks Read More »
Landing a job remains challenging for life sciences professionals, according to a new BioSpace report. While 59% of surveyed organizations are actively recruiting, nearly half of unemployed survey respondents had been out of work for at least six months, and 20% of surveyed employers expect to lay off employees this year.
Outside Looking In: Getting a Job Still Challenging, BioSpace Report Finds Read More »
Investment firm Bridgefield Capital will buy the segment, which includes cardiac resuscitation and emergency care devices, for an undisclosed amount.
Still, bankruptcy filings remained elevated, with the sector reaching the second-highest amount in the past six years, according to healthcare restructuring advisory firm Gibbins Advisors.
Healthcare bankruptcies declined in 2024: report Read More »
The company, co-founded by Nobel Laureate Craig Mello, aims to push molecules for Huntington’s and a form of epilepsy into Phase I trials, with additional preclinical assets targeting Parkinson’s and Alzheimer’s.
Atalanta Gets $97 Million Series B to Target Neurological Disorders With RNAi Read More »
Los estafilococos forman parte de la microbiota humana, el conjunto de bacterias que habita en la piel, el intestino, la boca y el tracto respiratorio superior, donde se encuentra en alrededor del 30% de la población, habitualmente en la piel y la nariz. La bacteria más común de …
Enhertu’s label expansion comes on the heels of the FDA’s approval of the partners’ Datroway for a related type of breast cancer.
AstraZeneca, Daiichi Sankyo Continue ADC Rally With Enhertu Expansion Read More »
